arrow
T

Tomomi Kamba

kumamoto university
H指数:32
被引数:4,577

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of treatment volume on outcomes for patients with penile cancer at relatively low-volume centers in Japan

治疗体积对日本相对低容量中心阴茎癌患者预后的影响

2026-08-010
PRE
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab

全基因组关联研究(GWAS)鉴定出与接受纳武利尤单抗治疗的晚期肾细胞癌患者严重不良事件及疗效相关的单核苷酸多态性(SNP)。

2025-09-240
OAAI
Risk Stratification for the Prognosis of Patients With pT3aN0M0 Clear Cell Renal Cell Carcinoma

pT3aN0M0透明细胞肾细胞癌患者预后的风险分层

2025-09-010
PRE
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan

体重指数对免疫联合疗法在转移性肾细胞癌中疗效的影响:一项在日本进行的多中心研究

2025-08-200
OAAI
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study
2024-05-170
OA
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events

衰老相关和CD4 T细胞依赖性异位CXCL13活化倾向于anti-PD-1治疗诱导的不良事件

2022-07-1134
OA
Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis
2022-06-201
OAAI
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease
2019-08-0151
OAAI